Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer. | Eur J Cancer | 2021 | 33743482 | PubTator, text mining | PubMed |
| A single donor is sufficient to produce a highly functional in vitro antibody library. | Commun Biol | 2021 | 33742103 | PubTator, text mining | PubMed |
| Next generation of immune checkpoint inhibitors and beyond. | J Hematol Oncol | 2021 | 33741032 | PubTator, text mining | PubMed |
| Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma. | Front Cell Dev Biol | 2021 | 33732694 | PubTator, text mining | PubMed |
| Recent Advances in Costimulatory Blockade to Induce Immune Tolerance in Liver Transplantation. | Front Immunol | 2021 | 33732228 | PubTator, text mining | PubMed |
| Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response. | Exp Anim | 2021 | 33716253 | PubTator, text mining | PubMed |
| Developmental exposure to chlordecone induces transgenerational effects in somatic prostate tissue which are associated with epigenetic histone trimethylation changes. | Environ Int | 2021 | 33711761 | PubTator, text mining | PubMed |
| B7-H6 is a new potential biomarker and therapeutic target of T-lymphoblastic lymphoma. | Ann Transl Med | 2021 | 33708955 | PubTator, text mining | PubMed |
| Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma. | Front Genet | 2021 | 33708242 | PubTator, text mining | PubMed |
| Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line. | PLoS One | 2021 | 33690729 | PubTator, text mining | PubMed |
| From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review. | Front Vet Sci | 2021 | 33681329 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Molecular and functional profiling of apical versus basolateral small extracellular vesicles derived from primary human proximal tubular epithelial cells under inflammatory conditions. | J Extracell Vesicles | 2021 | 33643548 | PubTator, text mining | PubMed |
| Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. | Cancer Cell Int | 2021 | 33637086 | PubTator, text mining | PubMed |
| Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance. | J Immunol Res | 2021 | 33628851 | PubTator, text mining | PubMed |
| Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation. | Nat Commun | 2021 | 33623012 | PubTator, text mining | PubMed |
| Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics. | J Cancer | 2021 | 33613752 | PubTator, text mining | PubMed |
| Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer. | Aging (Albany NY) | 2021 | 33612483 | PubTator, text mining | PubMed |
| Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages. | J Exp Clin Cancer Res | 2021 | 33596985 | PubTator, text mining | PubMed |
| The Immunology of Syncytialized Trophoblast. | Int J Mol Sci | 2021 | 33578919 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=64